Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor

Amino Acids

Volumn 14, Issue 1-3, 1998, Pages 175-179

  Kostrzewa, R M ^a   Brus, R ^b  

^a East Tennessee State University   (United States)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

6 hydroxydopa; 6 hydroxydopamine; Excitatory amino acids; Neurotoxicity; Noradrenergic neurons

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; 3 OXALYLAMINOALANINE; 6 HYDROXYDOPA; AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID DECARBOXYLASE; CATECHOLAMINE; EXCITOTOXIN; LEVODOPA; NALOXONE; NEUROTOXIN; NORADRENALIN; OPIATE; OXIDOPAMINE;

CONFERENCE PAPER; DRUG TRANSFORMATION; HUMAN; LATHYRISM; LOCUS CERULEUS; NERVE DEGENERATION; NEUROTOXICITY; NORADRENERGIC NERVE; PARKINSON DISEASE; PRIORITY JOURNAL;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; CATECHOLAMINES; DIHYDROXYPHENYLALANINE; HUMANS; NEURONS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS;

EID: 0031965228     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01345259     Document Type: Conference Paper

References (21)

1. Cha JH, Dure LS, Sakurai SY, Penney JB, Young AB (1991) 2,4,5-Trihydroxyphenylalanine (6-hydroxy-dopa) displaces [3H]AMPA binding in rat striatum. Neurosci Lett 132: 55-58
2. Clark MB, King JC, Kostrzewa RM (1979) Loss of nerve cell bodies in caudal locus coeruleus following treatment of neonates with 6-hydroxydopa. Neurosci Lett 13: 331-336
3. Harston CT, Clark MB, Hardin JC, Kostrzewa RM (1981) Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa. Eur J Pharm 71: 365-373
4. Jacobowitz D, Kostrzewa R (1971) Selective action of 6-hydroxydopa on noradrenergic terminals: mapping of preterminal axons of the brain. Life Sci 10: 1329-1341
5. Janes SM, Mu D, Wemmer D, Smith AJ, Kaur S, Maltby D, Burlingame AL (1990) A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science 248: 981-987
6. Kostrzewa RM (1998) 6-Hydroxydopa, a catecholamine neurotoxin and endogenous excitotoxin at non-NMDA receptors. In: Kostrzewa RM (ed) Highly selective neurotoxins: basic and clinical applications. Humana Press, Totowa, NJ (in press)
7. Kostrzewa RM, Garey RE (1977) Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6-hydroxydopa. Brain Res 124: 385-391
8. Kostrzewa RM, Harper JW (1974) Effects of 6-hydroxydopa on catecholamine-containing neurons in brains of newborn rats. Brain Res 69: 174-181
9. Kunig G, Hartmann J, Niedermeyer G, Deckert J, Ransmayr G, Heinsen H, Beckmann H, Riederer P (1994) Excitotoxins L-beta-oxalyl-amino-alanine (L-BOAA) and 3,4,6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampus. Neurosci Lett 169: 219-222
10. Metodiewa D, Reszka K, Dunford HB (1989) Oxidation of the substituted catechols dihydroxyphenylalanine methyl ester and trihydroxyphenylalanine by lactoperoxidase and its compounds. Arch Biochem Biophys 274: 601-608
11. Morrison ME, Yagi MJ, Cohen G (1985) In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells. Proc Natl Acad Sci 82: 2960-2964
12. Olney JW, Zorumski CF, Stewart GR, Price MT, Wang GH, Labruyere J (1990) Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases. Exp Neurol 108: 269-272
13. Ong HH, Creveling CR, Daly JW (1969) The synthesis of 2,4,5-trihydroxyphenylalanine (6-hydroxydopa). A centrally active norepinephrine-depleting agent. J Med Chem 12: 458-462
14. Pedersen JZ, el-Sherbini S, Finazzi-Agro A, Rotilio G (1992) A substrate-cofactor free radical intermediate in the reaction mechanism of copper amine oxidase. Biochemistry 31: 8-12
15. Pichorner H, Metodiewa D, Winterbourn CC (1995) Generation of Superoxide and tyrosine peroxide as a result of tyrosyl radical scavenging by glutathione. Arch Biochem Biophys 323: 429-437
16. Rosenberg PA, Loring R, Xie Y, Zaleskas V, Aizenman E (1991) 2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin. Proc Natl Acad Sci 88: 4865-4869
17. Sachs C, Jonsson G (1972) Selective 6-hydroxy-DOPA induced degeneration of central and peripheral noradrenaline neurons. Brain Res 40: 563-568
18. Thoenen H, Tranzer JP (1968) Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedebergs Arch Pharmacol Exp Pathol 261: 271-288
19. Weiss JH, Koh JY, Choi DW (1989) Neurotoxicity of beta-N-methylamino-L-alanine (BMAA) and beta-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res 497: 64-71
20. Wick MM, Byers L, Ratliff J (1979) Selective toxicity of 6-hydroxydopa for melanoma cells. J Invest Dermatol 72: 67-69
21. Zieher LM, Jaim-Etcheverry G (1975) Different alterations in the development of the noradrenergic innervation of the cerebellum and the brain stem produced by neonatal 6-hydroxydopa. Life Sci 17: 987-991